News
News
Group Company News
Launch of “CN™-9000 Automated Hemostasis Solution” for Large-Scale Laboratories in North America - Supporting the Optimization of Laboratory Workflow - (Sysmex America)
Sysmex America, Inc., a Sysmex Group company, has launched the “CN™-9000 Automated Hemostasis Solution” as a new addition to the CN-Series for hemostasis testing in the North American market.
This product supports further automation and increased efficiency in testing operations at large hospitals and testing centers with high test volumes. In addition to standalone operation, the CN™-9000 is compatible with Total Laboratory Automation (TLA) lines, enabling flexible system configurations tailored to the size and operational needs of each laboratory. For further details, please refer to Sysmex America’s press release.
▶ Sysmex America, Inc., News Release, January 21, 2026（https://www.sysmex.com/en-us/company/news-and-events/2026-sysmex-america-expands-cn-series-with-cn-9000-to-help-labs）
Going forward, Sysmex will continue to work to further enhance the value of hemostasis through product development and services that address the increasingly varied and sophisticated needs of medical settings, thereby contributing to improved patient outcomes.
- The purpose of this news is to communicate our business activities to our stakeholders. It may or may not include information about Sysmex's products or their research and development, but this is not intended for promotion, advertising, or medical advice. The information contained in this press release is current as of the date of the announcement but may be subject to change without prior notice.